Advanced Code injection

Arsheen Kaur 12/2/25 Arsheen Kaur 12/2/25

Morphocell Technologies completes US$50 Million Series A financing

Read More

Arsheen Kaur 12/2/25 Arsheen Kaur 12/2/25

Vasomune Therapeutics and AnGes expand the scope of the co-development agreement to target additional indications

Read More

Arsheen Kaur 12/2/25 Arsheen Kaur 12/2/25

Ripple Therapeutics enters collaboration with Bausch + Lomb

Read More

Arsheen Kaur 12/2/25 Arsheen Kaur 12/2/25

Kixcare partners with Manulife to provide 24x7 virtual care for children across Canada

Read More

Arsheen Kaur 12/2/25 Arsheen Kaur 12/2/25

FluidAI Medical announces an acquisition deal with Emmetros Limited

Read More

Arsheen Kaur 12/2/25 Arsheen Kaur 12/2/25

Capital BioVentures launches first cohort for the ASCENT program: Fit for funding, empowering breakthrough biotech

Read More

Arsheen Kaur 11/18/25 Arsheen Kaur 11/18/25

A4i secures multi-year contract with Riverside County in California

Read More

Arsheen Kaur 11/4/25 Arsheen Kaur 11/4/25

AmacaThera signs exclusive global licensing agreement with Pacira BioSciences for upto US$230M

Read More

Arsheen Kaur 11/4/25 Arsheen Kaur 11/4/25

Red Rock Regeneration secures first spot in Deloitte Canada's 2025 Technology Fast 50 program category

Read More

Arsheen Kaur 11/4/25 Arsheen Kaur 11/4/25

Conavi Medical announces agreement with the Province of Ontario as part of LSSUF

Read More

Arsheen Kaur 10/7/25 Arsheen Kaur 10/7/25

Vena Medical receives Health Canada licence for MicroAngioscope System™

Read More

Arsheen Kaur 10/7/25 Arsheen Kaur 10/7/25

The Globe and Mail's list of top growing companies

Read More

Arsheen Kaur 10/7/25 Arsheen Kaur 10/7/25

INOVAIT and the Government of Canada announce latest Pilot Fund recipients

Read More

Arsheen Kaur 10/7/25 Arsheen Kaur 10/7/25

Innovation Factory announces winners of 15th Annual LiONS LAIR competition

Read More

Arsheen Kaur 10/7/25 Arsheen Kaur 10/7/25

FluidAI Medical's Origin™ device receives FDA 510(k) clearance

Read More

Arsheen Kaur 9/24/25 Arsheen Kaur 9/24/25

20/20 OptimEyes Technologies recognized as the 2025 Blue Ticket Competition winner

Read More

Arsheen Kaur 9/22/25 Arsheen Kaur 9/22/25

ProteinQure announced first patient dosed in Phase I clinical trial of PQ203 in advanced metastatic cancer

Read More

Arsheen Kaur 9/10/25 Arsheen Kaur 9/10/25

Tiny device, huge impact: COBRA-OS shines on the cover of the September edition of Hospital News

Read More

Arsheen Kaur 9/10/25 Arsheen Kaur 9/10/25

Health Canada gives green light to new study investigating novel made-in-Canada drug candidate to prevent brain injury in hemodialysis patients

Read More

Arsheen Kaur 9/10/25 Arsheen Kaur 9/10/25

Noa Therapeutics received National Eczema Association Awards Grant to work with Johns Hopkins

Read More